Tissue inhibitor of metalloproteinase-1 alters the tumorigenicity of burkitt’s lymphoma via divergent effects on tumor growth and angiogenesis

American Journal of Pathology

Volumn 158, Issue 4, 2001, Pages 1207-1215

  Guedez, Liliana ^a   McMarlin, Andrew J ^a   Kingma, Douglas W ^a   Bennett, Teresa A ^a,b   Stetler Stevenson, Maryalice ^a   Stetler Stevenson, William G ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANGIOGENESIS; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; B CELL LYMPHOMA; BURKITT LYMPHOMA; CELL PROLIFERATION; CELL STRAIN; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR BIOPSY; TUMOR GROWTH; TUMOR NECROSIS; TUMOR REGRESSION;

EID: 0035066974     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64070-9     Document Type: Article

References (43)

1. Epstein-Barr virus infection
2. Regression of experimental human leukemias and solid tumors induced by Epstein-Barr virus-immortalized B cells
3. Regression of experimental Burkitt’s lymphoma induced by Epstein-Barr virus-immortalized human B Cells
4. Expression of the Epstein-Barr virus protein LPM1 mediates tumor regression in vivo
5. The role of Mig, the monokine induced by interferon-gamma, and IP-10, the interferon-gamma-inducible protein-10, in tissue necrosis and vascular damage associated with Epstein-Barr virus-positive lymphoproliferative disease
6. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover
7. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis
8. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes
9. Targeted disruption of the tissue inhibitor of metalloproteinases gene increases the invasive behavior of primitive mesenchymal cells derived from embryonic stem cells in vitro
10. Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells
11. Induction of angiogenesis in chick yolk-sac membrane by polyamines and its inhibition by tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2)
12. Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro
13. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase
14. Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases
15. Tumor cell invasion inhibited by TIMP-2
16. Insulin-like growth factor II signaling in neoplastic proliferation is blocked by transgenic expression of the metalloproteinase inhibitor TIMP-1
17. Altered tumor growth and metastasis of a T-cell lymphoma in timp-1 transgenic mice
18. High levels of TIMP-2 correlate with adverse prognosis in breast cancer
19. High preoperative plasma TIMP-1 levels are associated with short survival of patients with colorectal cancer
20. Serum matrix metalloproteinases-2, -9 and tissue inhibitors of metalloproteinases-1, -2 in lung cancer - TIMP-1 as a prognostic marker
21. Tissue inhibitor of matrix metalloproteinase-1 in the plasma of patients with gastric carcinoma - A possible marker for serosal invasion and metastasis
22. In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1
23. Tissue inhibitor of metalloproteinases-1 inhibits apoptosis of human breast epithelial cells
24. Tissue inhibitor of metalloproteinase-1 regulation of interleukin-10 in B cell differentiation and lymphomagenesis
25. The pathogenesis of Burkitt’s lymphoma
26. Tissue inhibitor of metalloproteinase (TIMP-1) induces differentiation of an antiapoptotic phenotype in germinal center B cells
27. Quantitative reverse zymography: Analysis using gelatinase A and B reverse zymograms
28. The role of matrix metalloproteinases activity in the maturation of human capillary endothelial cells in vitro
29. Inhibition of endothelial cell migration by gene transfer of tissue inhibitor of metalloproteinases-1
30. Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation
31. The role of metalloproteinases and their inhibitors in hematological disorders
32. Multiple functions of tissue inhibitors of metalloproteinases (TIMPs): New aspects in hematopoiesis
33. Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis
34. Growth regulated oncogene-alpha expression by murine squamous cell carcinoma promotes tumor growth, metastasis, leukocyte infiltration and angiogenesis by host CXC receptor-2 dependent mechanism
35. Neutrophil infiltrating the endometrium express vascular endothelial growth factor: Potential role in endometrial angiogenesis
36. Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3
37. The hallmarks of cancer
38. Breast cancer: Tumor neovasculature and the effect of tissue inhibitor of metalloproteinases-1 (TIMP-1) on angiogenesis
39. Clinical trails of antiangiogenic agents
40. Tyrosine phosphorylation is crucial for growth signaling by tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2)
41. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
42. Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas. Definitions, differential diagnosis, and epidemiology
43. The differentiated form of nasopharyngeal carcinomas contains Epstein-Barr virus DNA